Epicardial fat in heart failure—Friend, foe, or bystander
Obesity Reviews · 2024
DOI: 10.1111/obr.13820 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Obesity Reviews, 2024. Verfasst von Aleksandra Paterek und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Physiology, Centre of Postgraduate Medical Education, Warsaw, Poland. Hauptthemen laut MEDLINE: Heart Failure, Pericardium, Adipose Tissue. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 118 Literaturangaben. Gefördert von: Polish Cardiac Society Grant, National Institute of Cardiology Grant, Polskiego Towarzystwa Kardiologicznego.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Epicardial adipose tissue (EAT) is a fat depot covering the heart. No physical barrier separates EAT from the myocardium, so EAT can easily affect the underlying cardiac muscle. EAT can participate in the development and progression of heart failure with preserved (HFpEF) and reduced ejection fraction (HFrEF). In healthy humans, excess EAT is associated with impaired cardiac function and worse outcomes. In HFpEF, this trend continues: EAT amount is usually increased, and excess EAT correlates with worse function/outcomes. However, in HFrEF, the opposite is true: reduced EAT amount correlates with worse cardiac function/outcomes. Surprisingly, although EAT has beneficial effects on cardiac function, it aggravates ventricular arrhythmias. Here, we dissect these phenomena, trying to explain these paradoxical findings to find a target for novel heart failure therapies aimed at EAT rather than the myocardium itself. However, the success of this approach depends on a thorough understanding of interactions between EAT and the myocardium.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Physiology, Centre of Postgraduate Medical Education, Warsaw, Poland.
- Heart Failure and Transplantology Department, Mechanical Circulatory Support and Transplant Department, National Institute of Cardiology, Warsaw, Poland.
- Department of Clinical Neuroendocrinology, Centre of Postgraduate Medical Education, Warsaw, Poland.
ORCID-Profile: Michał Mączewski
Förderung
- Polish Cardiac Society Grant
- National Institute of Cardiology Grant
- Polskiego Towarzystwa Kardiologicznego
Zitieren
APA
Paterek, A., Załęska-Kocięcka, M., Wojdyńska, Z., Kalisz, M., Litwiniuk, A., Leszek, P., & Mączewski, M. (2024). Epicardial fat in heart failure—Friend, foe, or bystander. Obesity Reviews. https://doi.org/10.1111/obr.13820
Vancouver
Paterek A, Załęska-Kocięcka M, Wojdyńska Z, Kalisz M, Litwiniuk A, Leszek P, et al. Epicardial fat in heart failure—Friend, foe, or bystander. Obesity Reviews. 2024. doi:10.1111/obr.13820
BibTeX
@article{Paterek2024,
author = {Paterek, Aleksandra and Załęska-Kocięcka, Marta and Wojdyńska, Zuzanna and Kalisz, Małgorzata and Litwiniuk, Anna and Leszek, Przemysław and Mączewski, Michał},
title = {Epicardial fat in heart failure—Friend, foe, or bystander},
journal = {Obesity Reviews},
year = {2024},
doi = {10.1111/obr.13820}
}
EUVIMED